110 related articles for article (PubMed ID: 38669811)
1. Impact of data transfer between treatment planning systems on dosimetric parameters.
Meffe G; Votta C; Turco G; Chillè E; Nardini M; Romano A; Chiloiro G; Panza G; Galetto M; Capotosti A; Moretti R; Gambacorta MA; Boldrini L; Indovina L; Placidi L
Phys Med; 2024 May; 121():103369. PubMed ID: 38669811
[TBL] [Abstract][Full Text] [Related]
2. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.
Cusumano D; Boldrini L; Menna S; Teodoli S; Placidi E; Chiloiro G; Placidi L; Greco F; Stimato G; Cellini F; Valentini V; Azario L; De Spirito M
J Appl Clin Med Phys; 2019 Sep; 20(9):20-30. PubMed ID: 31444952
[TBL] [Abstract][Full Text] [Related]
4. Treatment plan quality during online adaptive re-planning.
van Timmeren JE; Chamberlain M; Krayenbuehl J; Wilke L; Ehrbar S; Bogowicz M; Hartley C; Zamburlini M; Andratschke N; Garcia Schüler H; Pavic M; Balermpas P; Ryu C; Guckenberger M; Tanadini-Lang S
Radiat Oncol; 2020 Aug; 15(1):203. PubMed ID: 32825848
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
6. MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers.
Prior P; Chen X; Botros M; Paulson ES; Lawton C; Erickson B; Li XA
Phys Med Biol; 2016 May; 61(10):3819-42. PubMed ID: 27089554
[TBL] [Abstract][Full Text] [Related]
7. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.
Wang S; Zheng D; Lin C; Lei Y; Verma V; Smith A; Ma R; Enke CA; Zhou S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819851520. PubMed ID: 31195891
[TBL] [Abstract][Full Text] [Related]
8. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer.
Dai ZT; Ma L; Cao TT; Zhu L; Zhao M; Li N
Sci Rep; 2021 Feb; 11(1):4065. PubMed ID: 33603030
[TBL] [Abstract][Full Text] [Related]
11. The impact of gadolinium-based MR contrast on radiotherapy planning for oropharyngeal treatment on the MR Linac.
Hales RB; Chuter R; McWilliam A; Salah A; Dubec M; Freear L; McDaid L; Aznar M; van Herk M; McPartlin A; Eccles CL
Med Phys; 2022 Jan; 49(1):510-520. PubMed ID: 34741308
[TBL] [Abstract][Full Text] [Related]
12. Knowledge-based planning using both the predicted DVH of organ-at risk and planning target volume.
Jiao SX; Wang ML; Chen LX; Liu XW
Med Eng Phys; 2022 Dec; 110():103803. PubMed ID: 35461772
[TBL] [Abstract][Full Text] [Related]
13. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images.
Young T; Lee M; Johnston M; Nguyen T; Ko R; Arumugam S
Phys Eng Sci Med; 2023 Dec; 46(4):1619-1627. PubMed ID: 37747645
[TBL] [Abstract][Full Text] [Related]
14. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional investigation into the robustness of intra-cranial multi-target stereotactic radiosurgery plans to delivery errors.
May L; Hardcastle N; Hernandez V; Saez J; Rosenfeld A; Poder J
Med Phys; 2024 Feb; 51(2):910-921. PubMed ID: 38141043
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
17. Direct dosimetric comparison of linear accelerator vs. Gamma Knife fractionated stereotactic radiotherapy (fSRT) of large brain tumors.
Calugaru E; Whiting Z; Delacruz B; Ma D; Garcia B; Goenka A; Chang J
Med Dosim; 2023 Spring; 48(1):31-36. PubMed ID: 36503990
[TBL] [Abstract][Full Text] [Related]
18. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
[TBL] [Abstract][Full Text] [Related]
19. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy.
Yadav P; Musunuru HB; Witt JS; Bassetti M; Bayouth J; Baschnagel AM
Radiol Oncol; 2019 Sep; 53(3):362-368. PubMed ID: 31553704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
